Article Information
History
- April 15, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Linzy Elton1,*,
- Alp Aydin2,
- Neil Stoker1,
- Sylvia Rofael1,3,
- Letícia Muraro Wildner1,
- Jabar Babatunde Pacome Agbo Achimi Abdul4,
- John Tembo5,
- Muzamil Abdel Hamid6,
- Mfoutou Mapanguy Claujens Chastel7,8,
- Julio Ortiz Canseco9,
- Ronan Doyle10,
- Giovanni Satta1,11,
- Justin O’Grady2,
- Adam Witney12,
- Francine Ntoumi7,8,
- Alimuddin Zumla1,13 and
- Timothy D McHugh1
- 1Centre for Clinical Microbiology, University College London, UK
- 2Oxford Nanopore Technologies plc. Quadram Institute, Rosalind Franklin Road, Norwich Research Park, Norwich, UK
- 3Faculty of Pharmacy, Alexandria University, Egypt
- 4Centre de Recherches Médicales de Lambaréné, Gabon
- 5HerpeZ, University Teaching Hospital, Lusaka, Zambia
- 6Institute for Endemic Diseases, University of Khartoum, Khartoum, Sudan
- 7Fondation Congolaise pour la Recherche Médicale, Republic of Congo
- 8Université Marien Ngouabi, Brazzaville Republic of Congo
- 9Francis Crick Institute, London, UK
- 10London School of Hygiene and Tropical Medicine, University of London, London, UK
- 11University College London Hospitals NHS Foundation Trust, London, UK
- 12St George’s, University of London, London, UK
- 13National Institute for Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK
- ↵*Corresponding author: Dr Linzy Elton, Centre for Clinical Microbiology, University College London, UK. Email: linzy.elton{at}ucl.ac.uk Tel: +44 (0)20 8016 8189
Posted April 15, 2024.
A pragmatic pipeline for drug resistance identification in Mycobacterium tuberculosis using whole genome sequencing
